{"filing":{"accession_number":"0001933414-26-000090","cik":"0001933414","ticker":"MLYS","company_name":"Mineralys Therapeutics, Inc.","form":"8-K","filing_date":"2026-05-22","report_date":null,"primary_document":"mlys-20260521.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1933414/000193341426000090/mlys-20260521.htm"},"events":[{"id":9227,"run_id":8095,"accession_number":"0001933414-26-000090","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear disclosure of shareholder vote results from the May 21, 2026 annual meeting of stockholders. The filing reports voting outcomes for two proposals: election of three Class III directors and ratification of Ernst \u0026 Young LLP as independent auditor, with specific vote tallies (For, Against/Withhold, Abstain, and Broker Non-Votes) for each proposal. Both proposals were approved. This directly matches Item 5.07 requirements and the shareholder_vote_results event type.","company_name":"Mineralys Therapeutics, Inc.","ticker":"MLYS","filing_date":"2026-05-22","form":"8-K","submitted_at":null,"items":[{"id":1337,"accession_number":"0001933414-26-000090","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from the May 21, 2026 annual meeting of stockholders. The filing reports voting outcomes for two proposals: election of three Class III directors and ratification of Ernst \u0026 Young LLP as independent auditor, with specific vote tallies (For, Against/Withhold, Abstain, and Broker Non-Votes) for each proposal. Both proposals were approved. This directly matches Item 5.07 requirements and the shareholder_vote_results event type.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-26T03:40:47.922568+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":1337,"accession_number":"0001933414-26-000090","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from the May 21, 2026 annual meeting of stockholders. The filing reports voting outcomes for two proposals: election of three Class III directors and ratification of Ernst \u0026 Young LLP as independent auditor, with specific vote tallies (For, Against/Withhold, Abstain, and Broker Non-Votes) for each proposal. Both proposals were approved. This directly matches Item 5.07 requirements and the shareholder_vote_results event type.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-26T03:40:47.922568+00:00","company_name":"Mineralys Therapeutics, Inc.","ticker":"MLYS","filing_date":"2026-05-22"}]}